Clinical Trials

A prospective, observational study to evaluate sex and toxicity differences in standard-of-care treatment for neuroendocrine neoplasms (NENs)
Not accepting volunteers
Other SkinNeoadjuvant Chemotherapy With or Without Cemiplimab (REGN2810) in Sinonasal Squamous Cell Carcinoma: A Randomized Phase 2 Study
Other HematopoieticA Phase 2a, Open-Label, Multicenter Study of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Other UrinaryAn Interventional Phase 1b/2, Open-Label Study to Investigate the Safety, Antitumor Activity, and Pharmacokinetics of PF-08634404 Monotherapy or in Combination With Enfortumab Vedotin in Adult Participants With Locally Advanced or Metastatic Urothelial Cancer
Brain and Nervous SystemA Phase II, Multicenter, Prospective Study of Sacituzumab Govitecan in Recurrent Glioblastoma